AILIS Breast Cancer Prediction Technology Company

AILIS is a pioneering technology that detect symptoms of breast cancer and estimate the risk of developing the illness.
Industry: AI
Headquarters: Kraków, Malopolskie, Poland
Founded Date: 01.01.2016
Employees Number: 11-50
Funding Status: Seed
Investors Number: 4
Total Funding: 3832000
Last Funding Date: 20.12.2021
Last Funding Type: Grant

Visit Website
contact@ailiscare.com
Register and Claim Ownership